Emerging research suggest Retatru tide , a dual activator targeting both GLP-1 and another hormone, could represent a promising advancement for weight loss . Early human investigations have indicated substantial decreases in body fat , potentially exceeding existing obesity therapies . Nevertheless , more study is necessary to fully understand its